Overview
Yul Chung practices in Seoul, Republic of Korea. Mr. Chung is rated as an Advanced expert by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Intraductal Papilloma, and Fibrocystic Breast Disease.
His clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Triple-Negative Breast Cancer.
Locations
Gyeonggi-do, Republic of Korea
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMr. Chung isAdvanced. Learn about Breast Cancer.
- Triple-Negative Breast CancerMr. Chung isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- Arteriovenous MalformationMr. Chung isExperienced. Learn about Arteriovenous Malformation.
- Fibrocystic Breast DiseaseMr. Chung isExperienced. Learn about Fibrocystic Breast Disease.
- Follicular Thyroid CancerMr. Chung isExperienced. Learn about Follicular Thyroid Cancer.
- Intraductal PapillomaMr. Chung isExperienced. Learn about Intraductal Papilloma.
- NecrosisMr. Chung isExperienced. Learn about Necrosis.
- Thyroid CancerMr. Chung isExperienced. Learn about Thyroid Cancer.